Literature DB >> 17236182

New perspectives into the biological and clinical relevance of oestrogen receptors in the human breast.

V Speirs1, R A Walker2.   

Abstract

Oestrogen receptor (ER) is arguably the single most important biological predictive factor that exists today. In the last 10 years or so, however, our understanding of ER biology has undergone a paradigm shift following the identification of a second ER, ERbeta, with the original ER being renamed ERalpha. A number of isoforms have additionally been described, especially for ERbeta. Our knowledge of ER signalling has also increased with the recognition of accessory co-regulatory proteins, which help direct the transcriptional cascade. Here we outline these changes and discuss what biological and clinical implications these could have in the mammary gland. Copyright (c) 2007 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17236182     DOI: 10.1002/path.2130

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  18 in total

1.  Role of ERalpha in the differential response of Stat5a loss in susceptibility to mammary preneoplasia and DMBA-induced carcinogenesis.

Authors:  Anne M Miermont; Angela R Parrish; Priscilla A Furth
Journal:  Carcinogenesis       Date:  2010-02-24       Impact factor: 4.944

Review 2.  Is soy consumption good or bad for the breast?

Authors:  Leena Hilakivi-Clarke; Juan E Andrade; William Helferich
Journal:  J Nutr       Date:  2010-10-27       Impact factor: 4.798

3.  Phosphorylation of estrogen receptor beta at serine 105 is associated with good prognosis in breast cancer.

Authors:  Werbena Hamilton-Burke; Louise Coleman; Michele Cummings; Caroline A Green; Deborah L Holliday; Kieran Horgan; Loaie Maraqa; Mark B Peter; Steven Pollock; Abeer M Shaaban; Laura Smith; Valerie Speirs
Journal:  Am J Pathol       Date:  2010-08-09       Impact factor: 4.307

4.  hPMC2 is required for recruiting an ERbeta coactivator complex to mediate transcriptional upregulation of NQO1 and protection against oxidative DNA damage by tamoxifen.

Authors:  S P Sripathy; L J Chaplin; N W Gaikwad; E G Rogan; M M Montano
Journal:  Oncogene       Date:  2008-07-28       Impact factor: 9.867

5.  Soy consumption and histopathologic markers in breast tissue using tissue microarrays.

Authors:  Gertraud Maskarinec; Eva Erber; Martijn Verheus; Brenda Y Hernandez; Jeffrey Killeen; Suzanne Cashin; J Mark Cline
Journal:  Nutr Cancer       Date:  2009       Impact factor: 2.900

6.  Estrogen receptor beta2 and beta5 are associated with poor prognosis in prostate cancer, and promote cancer cell migration and invasion.

Authors:  Yuet-Kin Leung; Hung-Ming Lam; Shulin Wu; Dan Song; Linda Levin; Liang Cheng; Chin-Lee Wu; Shuk-Mei Ho
Journal:  Endocr Relat Cancer       Date:  2010-06-25       Impact factor: 5.678

7.  Prevention of hormonal breast cancer by dietary jamun.

Authors:  Farrukh Aqil; Jeyaprakash Jeyabalan; Radha Munagala; Inder Pal Singh; Ramesh C Gupta
Journal:  Mol Nutr Food Res       Date:  2016-04-21       Impact factor: 5.914

8.  ERβ1 represses FOXM1 expression through targeting ERα to control cell proliferation in breast cancer.

Authors:  Yoshiya Horimoto; Johan Hartman; Julie Millour; Steven Pollock; Yolanda Olmos; Ka-Kei Ho; R Charles Coombes; Matti Poutanen; Sari I Mäkelä; Mona El-Bahrawy; Valerie Speirs; Eric W-F Lam
Journal:  Am J Pathol       Date:  2011-07-16       Impact factor: 4.307

9.  The Possible Impact of Obesity on Androgen, Progesterone and Estrogen Receptors (ERα and ERβ) Gene Expression in Breast Cancer Patients.

Authors:  R Jahanban Esfahlan; N Zarghami; A Jahanban Esfahlan; M Mollazadeh; K Nejati; M Nasiri
Journal:  Breast Cancer (Auckl)       Date:  2011-11-14

10.  Dual effects of TGF-beta on ERalpha-mediated estrogenic transcriptional activity in breast cancer.

Authors:  Yongsheng Ren; Liyu Wu; Andra R Frost; William Grizzle; Xu Cao; Mei Wan
Journal:  Mol Cancer       Date:  2009-11-27       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.